Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

2 terminated/withdrawn out of 10 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

10%

1 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A

7(70.0%)

Early Phase 1

2(20.0%)

Phase 4

1(10.0%)

10Total

N/A(7)

Early Phase 1(2)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT07566884Not ApplicableActive Not Recruiting

Safety and Tolerance of a Novel Three-Strain Probiotic in Healthy Adults

Role: lead

NCT07231588Early Phase 1Recruiting

Oral 5 Strain Probiotic for GI Toxicity Mitigation During Pelvic Radiation

Role: collaborator

NCT06992154Early Phase 1Not Yet Recruiting

Role of Akkermansia Muciniphila in Acne Vulgaris

Role: collaborator

NCT05348694Phase 4Unknown

OsteoPreP: Food Supplements for Postmenopausal Bone Health

Role: collaborator

NCT06213480Not ApplicableUnknown

Next-Generation Synbiotic in Individuals With Overweight or Obesity

Role: collaborator

NCT04424888Not ApplicableCompleted

Evaluating Use of Continuous Glucose Monitors in a Short-term 2x2-Crossover Study

Role: lead

NCT04047537Not ApplicableTerminated

Placebo-Controlled Clinical Nutrition Study of the Metabolic Effects of Food Product WBF-0011 in Type 2 Diabetes

Role: lead

NCT04228003Not ApplicableWithdrawn

Pendulum D2D Glucose Control for Adults With Type 2 Diabetes

Role: collaborator

NCT04490460Not ApplicableUnknown

Effects on Glycemic Control of WBF-0031 in Subjects With Abnormal Glucose Tolerance

Role: collaborator

NCT03893422Not ApplicableCompleted

Placebo-Controlled Clinical Nutrition Study of the Safety and Metabolic Effects of Two Medical Foods in Type 2 Diabetes

Role: lead

All 10 trials loaded